Fluicell AB 

SEK0.07
1
-SEK0-2.86% Wednesday 14:55

統計

當日最高
-
當日最低
-
52週最高
-
52週最低
-
成交量
-
平均成交量
-
市值
34.39M
市盈率
0.36
股息收益率
-
股息
-

收益

16Aug預期
Q1 2024
Q2 2024
999
333
-333
-999
預期每股收益
N/A
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 FLUI.ST 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Fluicell AB (publ) operates as a life science company, provides platforms and research solutions for bioprinting and single-cell biology. The company offers BIOPEN, a microfluidic platform for high-precision single-cell solution delivery that enables to control the cell microenvironment without moving or disturbing the cells; Biozone 6 that generate dose-response curves or study the effects of multiple drug compounds; and Dynaflow Resolve system, an ion channel screening platform, which allows to record various ion channel current in patch-clamp recording configuration. It also provides Biopixlar, a 3D single-cell bioprinting platform that enables high cell viability and cell-to-cell communication; and Biopixlar AER, an easy-to-use 3D bioprinting platform that fits into your fume hood or biosafety cabinet. The company also offers accessory and consumable products for bioprinting and single-cell biology. The company was incorporated in 2012 and is based in Mölndal, Sweden.
Show more...
首席執行官
Ms. Carolina Trjulja
員工
11
國家
Sweden

上市公司